Hans Melo

Yo, you gotta hear about Hans Melo, this guy’s a straight-up game changer in biotech and tech. So, he jumped into the startup scene with YC W20, which is already a big deal, right? But what really sets him apart is what he’s building now, Menten AI. This isn’t just another biotech company; they’re using quantum computing and machine learning to design peptides and proteins. Yeah, you heard that right, quantum tech in pharma. That’s advanced shit.

Hans is the CEO there, and he’s crushing it. Under his watch, Menten AI made the world’s first protein designed on a quantum computer. That’s not some small feat, that’s a total big change for drug discovery. Think about it: designing better, more stable protein therapeutics faster, cheaper, smarter. They’ve already secured seed funding from big names like Khosla Ventures and Uncork Capital, which shows the market sees how new this is.

Before all this, Hans was involved in other ventures, including being CEO of PCIS, so he’s no stranger to leading tech companies. His background screams tech entrepreneurship, he’s all about pushing the boundaries, taking big risks, and building stuff that actually matters. And his focus on biotech? That’s because he’s got this real motivation to solve hard problems, making medicine better, faster, more accessible. That’s what drives him.

He’s based out of SF, surrounded by the best in biotech and VC, and he’s already partnering with multinationals in pharma and biotech sectors. That really shows he’s not just playing in the lab, he’s making real moves to change how we develop drugs.

Bottom line? Hans Melo is one of those founders who’s not just talking, he’s actually doing shit that’s gonna shake up how medicine is made. His process? From tech entrepreneur to pioneering quantum-driven biotech, all driven by a desire to make an impact. No Cap, this guy’s the real deal.